2009
DOI: 10.1016/j.janxdis.2009.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Psychosocial predictors of the onset of anxiety disorders in women: Results from a prospective 3-year longitudinal study

Abstract: In a prospective, longitudinal, population-based study of 643 women participating in the Harvard Study of Moods and Cycles we examined whether psychosocial variables predicted a new or recurrent onset of an anxiety disorder. Presence of anxiety disorders was assessed every six months over three years via structured clinical interviews. Among individuals who had a new episode of anxiety, we confirmed previous findings that history of anxiety, increased anxiety sensitivity (the fear of anxiety related sensations… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
31
0
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(34 citation statements)
references
References 39 publications
2
31
0
1
Order By: Relevance
“…Second, our study was limited to 6-month follow-up. It would be interesting to extend the duration of follow-up to at least one year since remitted anxiety recurs in 24% of patients within 2 years [29] and more often in women (64% within 3 years) [30]. Also, more specific questions about benzodiazepine use as well as urine benzodiazepine assays could have been informative.…”
Section: Discussionmentioning
confidence: 99%
“…Second, our study was limited to 6-month follow-up. It would be interesting to extend the duration of follow-up to at least one year since remitted anxiety recurs in 24% of patients within 2 years [29] and more often in women (64% within 3 years) [30]. Also, more specific questions about benzodiazepine use as well as urine benzodiazepine assays could have been informative.…”
Section: Discussionmentioning
confidence: 99%
“…Those with a high sensitivity to anxiety might be particularly vulnerability to nonmedical benzodiazepine use. Anxiety sensitivity, a risk factor for anxiety disorder development (Calkins et al, 2009; Schmidt et al, 2010), is defined as the fear of anxiety symptoms and sensations (Peterson & Reiss, 1992; Reiss, Peterson, Gursky, & McNally, 1986). Anxiety sensitivity is hypothesized to amplify anxiety symptoms and thus to motivate attempts to avoid or escape these sensations.…”
Section: Introductionmentioning
confidence: 99%
“…Although many trials have examined the efficacy of short-term treatments in anxiety disorders, few trials have examined how those treatment gains are maintained (Batelaan et al, 2010; Bruce et al, 2005; Calkins et al, 2009; Rodriguez et al, 2005; Scholten et al, 2013). Anxiety recurrence is the emergence of symptoms after remission has been achieved.…”
Section: Introductionmentioning
confidence: 99%